PRODUCT FEATURES
Indirect chemiluminescent immunoassays (CLIA) for the detection of antibodies against Rubella henselae in human serum or plasma samples.
- Monotest format with ready-to-use reagents.
- Simple and automated protocol, with fast results.
- Customizable configuration of samples and reagents according to laboratory needs.
- Each monotest includes a calibrator and a negative control, enabling individual validation and interpretation of each sample.
- Use of primary tubes, with no need for manual pipetting.
PRODUCTS
RUBELLA VIRCLIA® IgG MONOTEST
Analytes: Rubella virus
RUBELLA VIRCLIA® IgM MONOTEST
Analytes: Rubella virus
USED ON
VIRCLIA® LOTUS
A compact automated CLIA platform for VirClia® infectious disease testing, combining ready-to-use single-test flexibility with continuous random access efficiency
MORE RESOURCES
Related germs and organisms categorized for this product line.
Downloadable PDF materials, brochures, and technical documents.
The latest insights, news, and research articles from our scientific team.
Measles in the Americas in 2026: strengthening laboratory diagnosis amid rising cases
Measles is once again a major public health concern across the Americas.After years of progress towards elimination, measles has made a significant co...
H. pylori stool antigen testing: when the test works, but the workflow no longer does
Helicobacter pylori stool antigen testing is an established non-invasive approach for detecting active H. pylori infection. Validated monoclonal stool...
Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...
Scientific bibliography and references related to this product.
